Compile Data Set for Download or QSAR
Report error Found 196 of ic50 data for polymerid = 464
TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280592(US10030020, Example 137 | US10781211, Example 137)
Affinity DataIC50: 100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280593(US10030020, Example 138 | US10781211, Example 138)
Affinity DataIC50: 100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280608(US10030020, Example 153 | US10781211, Example 153)
Affinity DataIC50: 100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280615(US10030020, Example 160 | US10781211, Example 160)
Affinity DataIC50: 100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280616(US10030020, Example 161 | US10781211, Example 161)
Affinity DataIC50: 100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280476(US10030020, Example 21 | US10781211, Example 21)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280477(US10030020, Example 22 | US10781211, Example 22)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280480(US10030020, Example 25 | US10781211, Example 25)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280481(US10030020, Example 26 | US10781211, Example 26)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280503(US10030020, Example 48 | US10781211, Example 48)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280513(US10030020, Example 58 | US10781211, Example 58)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280525(US10030020, Example 70)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280547(US10030020, Example 92 | US10781211, Example 92)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280558(US10030020, Example 103 | US10781211, Example 103)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280574(BDBM280666 | US10030020, Example 119 | US10781211,...)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280590(US10030020, Example 135 | US10781211, Example 135)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280591(US10030020, Example 136 | US10781211, Example 136)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280594(US10030020, Example 139 | US10781211, Example 139)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280595(US10030020, Example 140 | US10781211, Example 140)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280596(US10030020, Example 141 | US10781211, Example 141)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280607(US10030020, Example 152 | US10781211, Example 152)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280609(US10030020, Example 154 | US10781211, Example 154)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280610(US10030020, Example 155 | US10781211, Example 155)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280611(US10030020, Example 156 | US10781211, Example 156)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280612(US10030020, Example 157 | US10781211, Example 157)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280617(US10030020, Example 162 | US10781211, Example 162)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280618(US10030020, Example 163 | US10781211, Example 163)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280619(US10030020, Example 164 | US10781211, Example 164)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280636(US10030020, Example 181 | US10781211, Example 181)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280640(US10030020, Example 185 | US10781211, Example 185)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280641(US10030020, Example 186 | US10781211, Example 186)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280642(US10030020, Example 187 | US10781211, Example 187)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280643(US10030020, Example 188 | US10781211, Example 188)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280644(US10030020, Example 189 | US10781211, Example 189)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280647(US10030020, Example 192 | US10781211, Example 192)
Affinity DataIC50: 550nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280456(US10030020, Example 1 | US10781211, Example 1)
Affinity DataIC50: 1.00E+3nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280457(US10030020, Example 2 | US10781211, Example 2)
Affinity DataIC50: 1.00E+3nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280458(US10030020, Example 3 | US10781211, Example 3)
Affinity DataIC50: 1.00E+3nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280459(US10030020, Example 4 | US10781211, Example 4)
Affinity DataIC50: 1.00E+3nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280460(US10030020, Example 5 | US10781211, Example 5)
Affinity DataIC50: 1.00E+3nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280461(US10030020, Example 6 | US10781211, Example 6)
Affinity DataIC50: 1.00E+3nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280462(US10030020, Example 7 | US10781211, Example 7)
Affinity DataIC50: 1.00E+3nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280463(US10030020, Example 8 | US10781211, Example 8)
Affinity DataIC50: 1.00E+3nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280464(US10030020, Example 9 | US10781211, Example 9)
Affinity DataIC50: 1.00E+3nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280465(US10030020, Example 10 | US10781211, Example 10)
Affinity DataIC50: 1.00E+3nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280466(US10030020, Example 11 | US10781211, Example 11)
Affinity DataIC50: 1.00E+3nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280467(US10030020, Example 12 | US10781211, Example 12)
Affinity DataIC50: 1.00E+3nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280468(US10030020, Example 13 | US10781211, Example 13)
Affinity DataIC50: 1.00E+3nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280469(US10030020, Example 14 | US10781211, Example 14)
Affinity DataIC50: 1.00E+3nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMonoacylglycerol lipase ABHD2(Mouse)
Abide Therapeutics

US Patent
LigandPNGBDBM280470(US10030020, Example 15 | US10781211, Example 15)
Affinity DataIC50: 1.00E+3nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

Displayed 1 to 50 (of 196 total ) | Next | Last >>
Jump to: